390 related articles for article (PubMed ID: 27103451)
1. Microparticle Shedding by Erythrocytes, Monocytes and Vascular Smooth Muscular Cells Is Reduced by Aspirin in Diabetic Patients.
Chiva-Blanch G; Suades R; Padró T; Vilahur G; Peña E; Ybarra J; Pou JM; Badimon L
Rev Esp Cardiol (Engl Ed); 2016 Jul; 69(7):672-80. PubMed ID: 27103451
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.
Bethel MA; Harrison P; Sourij H; Sun Y; Tucker L; Kennedy I; White S; Hill L; Oulhaj A; Coleman RL; Holman RR
Diabet Med; 2016 Feb; 33(2):224-30. PubMed ID: 26043186
[TBL] [Abstract][Full Text] [Related]
3. Microparticle Shedding from Neural Progenitor Cells and Vascular Compartment Cells Is Increased in Ischemic Stroke.
Chiva-Blanch G; Suades R; Crespo J; Peña E; Padró T; Jiménez-Xarrié E; Martí-Fàbregas J; Badimon L
PLoS One; 2016; 11(1):e0148176. PubMed ID: 26815842
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty.
Wilson AM; Brittenden J; Bachoo P; Ford I; Nixon GF
J Vasc Surg; 2009 Oct; 50(4):861-9. PubMed ID: 19786240
[TBL] [Abstract][Full Text] [Related]
5. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
[TBL] [Abstract][Full Text] [Related]
6. Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Iwasaka T; Fukuhara S
Clin Appl Thromb Hemost; 2004 Jul; 10(3):205-15. PubMed ID: 15247977
[TBL] [Abstract][Full Text] [Related]
7. Platelet Microparticles Mediate Glomerular Endothelial Injury in Early Diabetic Nephropathy.
Zhang Y; Ma KL; Gong YX; Wang GH; Hu ZB; Liu L; Lu J; Chen PP; Lu CC; Ruan XZ; Liu BC
J Am Soc Nephrol; 2018 Nov; 29(11):2671-2695. PubMed ID: 30341150
[TBL] [Abstract][Full Text] [Related]
8. Microparticles as new markers of cardiovascular risk in diabetes and beyond.
Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G
Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919
[TBL] [Abstract][Full Text] [Related]
9. The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus.
Lemkes BA; Bähler L; Kamphuisen PW; Stroobants AK; Van Den Dool EJ; Hoekstra JB; Nieuwland R; Gerdes VE; Holleman F
J Thromb Haemost; 2012 Apr; 10(4):639-46. PubMed ID: 22252020
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
Capodanno D; Patel A; Dharmashankar K; Ferreiro JL; Ueno M; Kodali M; Tomasello SD; Capranzano P; Seecheran N; Darlington A; Tello-Montoliu A; Desai B; Bass TA; Angiolillo DJ
Circ Cardiovasc Interv; 2011 Apr; 4(2):180-7. PubMed ID: 21386092
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity.
Valles J; Santos MT; Aznar J; Osa A; Lago A; Cosin J; Sanchez E; Broekman MJ; Marcus AJ
Circulation; 1998 Feb; 97(4):350-5. PubMed ID: 9468208
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
13. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes.
Kapłon-Cieślicka A; Rosiak M; Postuła M; Serafin A; Kondracka A; Opolski G; Filipiak KJ
Kardiol Pol; 2013; 71(9):893-902. PubMed ID: 24065375
[TBL] [Abstract][Full Text] [Related]
14. FLow-induced PRotrusions (FLIPRs): a platelet-derived platform for the retrieval of microparticles by monocytes and neutrophils.
Tersteeg C; Heijnen HF; Eckly A; Pasterkamp G; Urbanus RT; Maas C; Hoefer IE; Nieuwland R; Farndale RW; Gachet C; de Groot PG; Roest M
Circ Res; 2014 Feb; 114(5):780-91. PubMed ID: 24406984
[TBL] [Abstract][Full Text] [Related]
15. Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers.
Pistrosch F; Matschke JB; Schipp D; Schipp B; Henkel E; Weigmann I; Sradnick J; Bornstein SR; Birkenfeld AL; Hanefeld M
Diabetologia; 2021 Dec; 64(12):2701-2712. PubMed ID: 34495376
[TBL] [Abstract][Full Text] [Related]
16. Effects of transplanted circulating endothelial progenitor cells and platelet microparticles in atherosclerosis development.
Georgescu A; Alexandru N; Andrei E; Dragan E; Cochior D; Dias S
Biol Cell; 2016 Aug; 108(8):219-43. PubMed ID: 26968123
[TBL] [Abstract][Full Text] [Related]
17. Small-size Microparticles as Indicators of Acute Decompensated State in Ischemic Heart Failure.
Montoro-García S; Shantsila E; Wrigley BJ; Tapp LD; Abellán Alemán J; Lip GY
Rev Esp Cardiol (Engl Ed); 2015 Nov; 68(11):951-8. PubMed ID: 25819989
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus.
Santilli F; Lapenna D; La Barba S; Davì G
Free Radic Biol Med; 2015 Mar; 80():101-10. PubMed ID: 25530150
[TBL] [Abstract][Full Text] [Related]
19. Perioperative platelet and monocyte activation in patients with critical limb ischemia.
Burdess A; Nimmo AF; Campbell N; Harding SA; Garden OJ; Dawson AR; Newby DE
J Vasc Surg; 2010 Sep; 52(3):697-703. PubMed ID: 20816321
[TBL] [Abstract][Full Text] [Related]
20. microRNA expression profile in human coronary smooth muscle cell-derived microparticles is a source of biomarkers.
de Gonzalo-Calvo D; Cenarro A; Civeira F; Llorente-Cortes V
Clin Investig Arterioscler; 2016; 28(4):167-77. PubMed ID: 27363781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
